2020
DOI: 10.1186/s13326-020-00228-8
|View full text |Cite
|
Sign up to set email alerts
|

Identifying disease trajectories with predicate information from a knowledge graph

Abstract: Background: Knowledge graphs can represent the contents of biomedical literature and databases as subjectpredicate-object triples, thereby enabling comprehensive analyses that identify e.g. relationships between diseases. Some diseases are often diagnosed in patients in specific temporal sequences, which are referred to as disease trajectories. Here, we determine whether a sequence of two diseases forms a trajectory by leveraging the predicate information from paths between (disease) proteins in a knowledge gr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 60 publications
0
6
0
Order By: Relevance
“…In particular, the proposed methods can be employed in discovering disease trajectories, which can reveal disease correlations and temporal disease progression, thus equipping clinicians with tools for predicting and preventing future complications in individual patients [ 46 ]. Previous studies have based their solutions for discovering disease trajectories on statistical analysis [ 47 ] and knowledge graphs [ 48 ]. Both approaches have their limitations: while the former approach is prone to statistical bias, the latter is not scalable and requires significant expert input.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the proposed methods can be employed in discovering disease trajectories, which can reveal disease correlations and temporal disease progression, thus equipping clinicians with tools for predicting and preventing future complications in individual patients [ 46 ]. Previous studies have based their solutions for discovering disease trajectories on statistical analysis [ 47 ] and knowledge graphs [ 48 ]. Both approaches have their limitations: while the former approach is prone to statistical bias, the latter is not scalable and requires significant expert input.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from DIAMOnD and the graphlets, the disease gene identification methods tested by us were trained and evaluated using the supervised learning algorithms that were used in the original studies. These are: logistic regression (LR) (used by Agrawal et al [ 35 ] and by Ristoski et al [ 36 ]), support-vector machines (SVM) (used by Peng et al [ 37 ]), decision trees (DT) (used by Ristoski et al [ 36 ]), and random forest (RF) (used by Vlietstra et al [ 19 ]). We excluded the K-nearest neighbour classifiers used by Xu et al [ 38 ], Ristoski et al [ 36 ], and Milenković et al [ 39 ] due to their limited ability to rank, often leading to tied ranks for genes.…”
Section: Methodsmentioning
confidence: 99%
“…Predicates between genes have not yet been used for disease gene identification, but previous research has leveraged predicates and their directional information from protein knowledge graphs to improve performance for drug efficacy screening and identification of disease trajectories [ 17 , 19 ].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations